A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects

被引：0
|
作者：
Hironobu Tsukada
Yu-Luan Chen
Guangqing Xiao
Lisa Lennek
Snezana M. Milanovic
MaryAlice Worden
Daniel G. Polhamus
Yu-Yuan Chiu
Seth C. Hopkins
Gerald R. Galluppi
机构：
[1] Sumitomo Pharma America,
[2] Sumitomo Pharma Co.,undefined
[3] Ltd,undefined
[4] Metrum Research Group,undefined
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1755 / 1763
页数：8
相关论文
共 50 条
  • [1] A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects
    Tsukada, Hironobu
    Chen, Yu-Luan
    Xiao, Guangqing
    Lennek, Lisa
    Milanovic, Snezana M.
    Worden, Maryalice
    Polhamus, Daniel G.
    Chiu, Yu-Yuan
    Hopkins, Seth C.
    Galluppi, Gerald R.
    CLINICAL PHARMACOKINETICS, 2023, 62 (12) : 1755 - 1763
  • [2] Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects
    Pei, Qi
    Peng, Jinfu
    Tan, Hongyi
    Yang, Liu
    Yang, Xiding
    Liu, Li
    Liu, Shikun
    Yuan, Hong
    Yang, Guoping
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (04) : 427 - 433
  • [3] Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects
    Qi Pei
    Jinfu Peng
    Hongyi Tan
    Liu Yang
    Xiding Yang
    Li Liu
    Shikun Liu
    Hong Yuan
    Guoping Yang
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 427 - 433
  • [4] Inhibition of human cytochrome P450 2D6 by schering 66712
    Butler, Brendan Francis
    Palamanda, Jairam
    Nomeir, Amin A.
    Guengerich, F. Peter
    Furge, Laura Lowe
    FASEB JOURNAL, 2007, 21 (05): : A670 - A670
  • [5] The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults
    Nichols, Alice I.
    Fatato, Penny
    Shenouda, Magdy
    Paul, Jeffrey
    Isler, Jennifer A.
    Pedersen, Ronald D.
    Jiang, Qin
    Ahmed, Saeeduddin
    Patroneva, Albena
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02): : 219 - 228
  • [6] Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjects
    Tachibana, Masaya
    Matsuki, Shunji
    Maekawa, Yutaro
    Kuroda, Kana
    Shimizu, Takako
    Tsutsumi, Junko
    Ishizuka, Hitoshi
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (11): : 2153 - 2162
  • [7] Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
    Wilner, KD
    Demattos, SB
    Anziano, RJ
    Apseloff, G
    Gerber, N
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 : 43S - 47S
  • [8] Lisdexamfetamine dimesylate effects on the pharmacokinetics of cytochrome P450 substrates in healthy adults in an open-label, randomized, crossover study
    Ermer J.
    Corcoran M.
    Martin P.
    Drugs in R&D, 2015, 15 (2) : 175 - 185
  • [9] Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
    Rebecca E. Wrishko
    Jacqueline B. McCrea
    Ka Lai Yee
    Wen Liu
    Deborah Panebianco
    Eric Mangin
    Manu Chakravarthy
    Maria P. Martinez-Cantarin
    Walter K. Kraft
    Clinical Drug Investigation, 2019, 39 : 453 - 454
  • [10] Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System
    Preskorn, Sheldon H.
    Nichols, Alice I.
    Paul, Jeffrey
    Patroneva, Albena L.
    Helzner, Eileen C.
    Guico-Pabia, Christine J.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (06) : 368 - 378
12345